📰 Events Presentations News
Page 2 - Events Presentations News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Events Presentations. Real-time updates on events, politics, business and more.
November 7, 2022
ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 15th
September 6, 2022
ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at Morgan Stanley's 20th Annual Global Healthcare Conference on Tuesday
August 30, 2022
Isaralgagene civaparvovec, or ST-920, continued to be generally well tolerated across three dose cohorts in the six treated patients The five longest treated patients exhibited elevated a-Gal A activity
August 12, 2022
GBDC earnings call for the period ending June 30, 2022.
August 3, 2022
Enviva Inc. (NYSE: EVA) ("Enviva," the "Company," "we," "us," or "our") today announced financial and operating results and declared a dividend for the second quarter of 2022. Enviva also announced four
June 3, 2022
Newell Brands Inc. (NASDAQ: NWL) announced today that Chief Executive Officer, Ravi Saligram, and President and Chief Financial Officer, Chris Peterson, will participate in a fireside chat at the dbAccess
June 1, 2022
ADC Therapeutics SA (NYSE: ADCT) announced today that its Chief Executive Officer, Ameet Mallik, will be participating in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 8,
May 23, 2022
Today, at Walpole's latest Luxury Summit in London, Global Blue will present new data signalling the continued recovery of Tax Free Shopping in continental Europe During the first few months
May 12, 2022
Golub Capital BDC (NASDAQ:NASDAQ:GBDC) Q2 2022 Earnings Conference Call May 11, 2022 03:00 PM ET Company Participants David Golub - Chief Executive Officer Greg Robbins - Senior Managing...
May 4, 2022
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company improving the lives of those affected by cancer with its next-generation, targeted antibody drug conjugates (ADCs) for patients